Cadiz M, Gibson K, Todd K, Nascari D, Massa N, Lilley M
J Exp Med. 2024; 221(2).
PMID: 38226975
PMC: 10791560.
DOI: 10.1084/jem.20231363.
Brandao-Teles C, Antunes A, de Moraes Vrechi T, Martins-de-Souza D
Mol Neurobiol. 2023; 61(6):3578-3595.
PMID: 37999871
DOI: 10.1007/s12035-023-03747-4.
Yoon J, Hwang J, Son S, Choi J, You S, Park H
Int J Mol Sci. 2023; 24(4).
PMID: 36834911
PMC: 9966425.
DOI: 10.3390/ijms24043506.
Beach T
J Neuropathol Exp Neurol. 2022; 81(6):387-413.
PMID: 35595841
PMC: 9122832.
DOI: 10.1093/jnen/nlac030.
Dong Q, Gentry N, McMahon T, Yamazaki M, Benitez-Rivera L, Wang T
iScience. 2022; 25(4):103964.
PMID: 35496999
PMC: 9042888.
DOI: 10.1016/j.isci.2022.103964.
Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
Coughlin D, Ittyerah R, Peterson C, Phillips J, Miller S, Rascovsky K
Neuropathol Appl Neurobiol. 2020; 46(7):707-721.
PMID: 32892355
PMC: 7787184.
DOI: 10.1111/nan.12659.
Clinicopathological correlates of Alzheimer's disease in a general autopsy series from Brazil.
Grinberg L, Ferretti R, Leite R, Farfel J, Pacheco S, Alho A
Dement Neuropsychol. 2017; 1(4):356-360.
PMID: 29213411
PMC: 5619429.
DOI: 10.1590/S1980-57642008DN10400005.
Interrelationship between Changes in the Amyloid β 42/40 Ratio and Presenilin 1 Conformation.
Zoltowska K, Maesako M, Berezovska O
Mol Med. 2016; 22:329-337.
PMID: 27391800
PMC: 5023509.
DOI: 10.2119/molmed.2016.00127.
Effects of Low Amyloid-β (Aβ) Concentration on Aβ1-42 Oligomers Binding and GluN2B Membrane Expression.
Gilson V, Mbebi-Liegeois C, Sellal F, de Barry J
J Alzheimers Dis. 2015; 47(2):453-66.
PMID: 26401567
PMC: 4923730.
DOI: 10.3233/JAD-142529.
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.
Beach T, Adler C, Sue L, Serrano G, Shill H, Walker D
Neuropathology. 2015; 35(4):354-89.
PMID: 25619230
PMC: 4593391.
DOI: 10.1111/neup.12189.
In vivo characterization of the early states of the amyloid-beta network.
Sepulcre J, Sabuncu M, Becker A, Sperling R, Johnson K
Brain. 2013; 136(Pt 7):2239-52.
PMID: 23801740
PMC: 3692037.
DOI: 10.1093/brain/awt146.
The effect of cyclodextrin-solubilized curcuminoids on amyloid plaques in Alzheimer transgenic mice: brain uptake and metabolism after intravenous and subcutaneous injection.
Quitschke W, Steinhauff N, Rooney J
Alzheimers Res Ther. 2013; 5(2):16.
PMID: 23537472
PMC: 3706801.
DOI: 10.1186/alzrt170.
Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.
Nelson P, Braak H, Markesbery W
J Neuropathol Exp Neurol. 2008; 68(1):1-14.
PMID: 19104448
PMC: 2692822.
DOI: 10.1097/NEN.0b013e3181919a48.
Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease.
Oh E, Troncoso J, Tucker S
Neuromolecular Med. 2008; 10(3):195-207.
PMID: 18543125
PMC: 2558671.
DOI: 10.1007/s12017-008-8035-0.
Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
Rozemuller A, Roos R, BOTS G, Kamphorst W, Eikelenboom P, Van Nostrand W
Am J Pathol. 1993; 142(5):1449-57.
PMID: 7684195
PMC: 1886931.
Analysis of staining methods for different cortical plaques in Alzheimer's disease.
Halliday G, Flowers D, Baum L
Acta Neuropathol. 1994; 87(2):174-86.
PMID: 7513488
DOI: 10.1007/BF00296188.
Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia.
Braak H, Braak E
Acta Neuropathol. 1990; 80(5):479-86.
PMID: 2251904
DOI: 10.1007/BF00294607.
Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin.
Rozemuller J, Abbink J, Kamp A, STAM F, Hack C, Eikelenboom P
Acta Neuropathol. 1991; 82(3):200-7.
PMID: 1927277
DOI: 10.1007/BF00294446.
Neuropathological stageing of Alzheimer-related changes.
Braak H, Braak E
Acta Neuropathol. 1991; 82(4):239-59.
PMID: 1759558
DOI: 10.1007/BF00308809.
Alzheimer's disease affects limbic nuclei of the thalamus.
Braak H, Braak E
Acta Neuropathol. 1991; 81(3):261-8.
PMID: 1711755
DOI: 10.1007/BF00305867.